Brian Normand
Co-Founder | Board of Directors
Brian Normand is an editor, producer, and co-founder of Psymposia. Since 2014 he has collaborated with the most influential people working in psychedelics and drug policy to produce dozens of high impact events and conversations at universities and venues in the United States, Mexico, and Europe.
His strategic direction and visual design has helped shape both the direction and character of Psymposia through the years. He has also helped organize numerous events with MAPS, including Psychedelic Science 2017.
Brian became interested in psychedelics as a teenager from listening to Bill Hicks and reading Aldous Huxley, and as a treatment for depression after losing his mother to suicide. After his arrest and prosecution for cannabis and mushroom cultivation, he completed a B.S. in Plant, Soil, and Insect Science from UMass Amherst, where he helped organize the first-ever psychedelics conference on campus. Brian’s work focuses on the effects of drug prohibition in the United States and Latin America, and the impact of corporations on psychedelia.
Brian Normand
Brian Normand is an editor, producer, and co-founder of Psymposia. Since 2014 he has collaborated with the most influential people working in psychedelics and drug policy to produce dozens of high impact events and conversations at universities and venues in the United States, Mexico, and Europe.
His strategic direction and visual design has helped shape both the direction and character of Psymposia through the years. He has also helped organize numerous events with MAPS, including Psychedelic Science 2017.
Brian became interested in psychedelics as a teenager from listening to Bill Hicks and reading Aldous Huxley, and as a treatment for depression after losing his mother to suicide. After his arrest and prosecution for cannabis and mushroom cultivation, he completed a B.S. in Plant, Soil, and Insect Science from UMass Amherst, where he helped organize the first-ever psychedelics conference on campus. Brian’s work focuses on the effects of drug prohibition in the United States and Latin America, and the impact of corporations on psychedelia.